Paul Gueguen

Title: Paul Gueguen: Innovator in Blood Coagulation Treatment

Introduction

Paul Gueguen is a notable inventor based in Brest, France. He has made significant contributions to the field of medical research, particularly in the area of blood coagulation disorders. With a total of 3 patents to his name, Gueguen's work is recognized for its innovative approach to treatment.

Latest Patents

Gueguen's latest patents focus on serine protease derivatives and their applications in preventing or treating blood coagulation disorders. His inventions include chimeric derivatives of serine protease zymogen that contain the activation peptide of factor X or a fragment thereof. These derivatives are designed to improve the half-life of the proteins, specifically targeting protein C and factor X derivatives. The inventions aim to provide effective solutions for individuals suffering from blood coagulation issues.

Career Highlights

Paul Gueguen is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research and development. His work has been instrumental in advancing the understanding and treatment of coagulation disorders, showcasing his commitment to medical innovation.

Collaborations

Gueguen collaborates with esteemed colleagues such as Olivier Christophe and Cecile Denis. Their combined expertise contributes to the success of their research initiatives and the development of groundbreaking medical solutions.

Conclusion

In summary, Paul Gueguen is a distinguished inventor whose work in blood coagulation treatment has the potential to significantly impact medical practices. His innovative patents and collaborations highlight his dedication to improving health outcomes for patients.